Discovery of a tetrazolyl β-carboline within vitroandin vivoosteoprotective activity under estrogen-deficient conditions
- 12 June 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 9 (7) , 1213-1225
Abstract
β-Carbolines have been assessed for osteoclastogenesis. However, their effect on osteoblasts during estrogen deficiency is still unclear. Here, a series of novel piperazine and tetrazole tag β-carbolines have been synthesized and examined for osteoblast differentiation in vitro. In vitro data suggest that compound 8g is the most promising osteoblast differentiating agent that was evaluated for in vivo studies. Compound 8g promoted osteoblast mineralization, stimulated Runx2, BMP-2 and OCN expression levels, increased BrdU incorporation and inhibited generation of free radicals as well as nitric oxide. Since a piperazine group is involved in bone repair activity and β-carboline in IκB kinase (IKK) inhibition, compound 8g inhibited tumor necrosis factor α (TNFα) directed IκBα phosphorylation, preventing nuclear translocation of NF-κB thereby alleviating osteoblast apoptosis. In vivo studies show that compound 8g was able to restore estrogen deficiency-induced bone loss in ovariectomized rats without any toxicity, thus signifying its potential in bone-protection chemotherapy under postmenopausal conditions.Keywords
Funding Information
- Council of Scientific and Industrial Research
- University Grants Commission
This publication has 57 references indexed in Scilit:
- MicroCT morphometry analysis of mouse cancellous bone: Intra- and inter-system reproducibilityBone, 2011
- A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: The role of aryl hydrocarbon receptor as a mediator of osteogenic actionJournal of Bone and Mineral Research, 2011
- Evidence of specific characteristics and osteogenic potentiality in bone cells from tibiaJournal of Cellular Physiology, 2011
- Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivoEuropean Journal of Pharmacology, 2011
- Methoxylated isoflavones, cajanin and isoformononetin, have non‐estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signalingJournal of Cellular Biochemistry, 2009
- Inhibition of osteoblastic bone formation by nuclear factor-κBNature Medicine, 2009
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Estrogen deficiency and bone loss: an inflammatory taleJournal of Clinical Investigation, 2006
- Aldose reductase regulates TNF‐α‐induced cell signaling and apoptosis in vascular endothelial cellsFEBS Letters, 2004
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003